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Abstract
IL-22 produced by innate lymphoid cells (ILCs) and CD4+ T cells plays an important role in host
defense and mucosal homeostasis, thus it is important to investigate the mechanisms that regulate
IL-22 production. We investigated the regulation IL-22 production by CD4+ T cells. Here we
show that IL-21 triggers IL-22, but not IL-17 production by CD4+ T cells. STAT3, activated by
IL-21, controls the epigenetic status of the il22 promoter and its interaction with the aryl
hydrocarbon receptor (AhR). Moreover, IL-21 and AhR signaling in T cells control IL-22
production and the development of dextran sodium sulfate-induced colitis in ILC-deficient mice.
Thus, we have identified IL-21 as an inducer of IL-22 production in CD4+ T cells in vitro and in
vivo.
Introduction
IL-22 is a member of the IL-10 family of cytokines; cytokines in this family display
homologous secondary structures and 20%-30% amino acid identity1. IL-22 acts on non-
hematopoietic cells in epithelial tissues, which express a functional IL-22 receptor
composed of an heterodimer of IL-22R1 and IL-10R22, 3. IL-22 signaling triggers the
production of anti-microbial peptides and pro-inflammatory molecules, and it also promotes
tissue repair by inducing epithelial cell proliferation and survival2, 3. These effects of IL-22
are thought to be responsible for its important role in the control of host defense against
bacterial infections, and also in limiting tissue destruction during hepatitis, colitis, graft
versus host disease and thymus involution4-9. Conversely, dysregulated IL-22 signaling
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tcontributes to the pathogenesis of psoriasis, arthritis, inflammatory bowel disease and colon
cancer10-13.
IL-22 is produced by cells of the innate system, particularly innate lymphoid cells (ILCs),
and also by CD4+ T cells, CD8+ T cells and γδ T cells2, 3. ILCs expressing the transcription
factor RORγt are an important source of IL-22 in vivo14. Following activation with IL-23 or
IL-1β, RORγt+ ILCs produce IL-22 through a mechanism controlled by the ligand-activated
transcription factor aryl hydrocarbon receptor (AhR)15-17. AhR signaling is also critical for
the development of ILCs, thus it has been postulated that AhR ligands in the diet or
produced by commensal bacteria regulate ILC development and function15-17. However,
commensal bacteria can also promote IL-22 production through AhR-independent
mechanisms, for example by inducing the production of IL-1β and IL-23 by myeloid
cells18, 19.
CD4+ T cells also produce significant amounts of IL-22. We20 and others21-23 have shown
that AhR signaling regulates the production of IL-22 by Th17 cells differentiated in the
presence of IL-6 and TGFβ1. Indeed, the production of IL-22 by IL-17+ CD4+ T cells has
been shown to limit tissue destruction during experimental acute hepatitis7 and
inflammatory bowel disease (IBD)8, 24. Although IL-22 expression is usually linked to Th17
cells25, human and murine CD4+ T cells that produce high amounts of IL-22 but not IL-17
have also been identified13, 25-28. These CD4+ IL-22+ IL-17- T cells play a protective role
in mucosal antimicrobial host defense9, 29. Thus, considering the significant role of IL-22
produced by CD4+ T cells in host defense and mucosal barrier integrity it is important to
investigate the mechanisms that regulate IL-22 production in T cells.
In vitro, the activation of naïve CD4+ T cells in the presence of cytokines that trigger
STAT3 activation, such as IL-6, triggers the production of IL-22 but almost no IL-1713.
IL-21, a cytokine that belongs to the type I four-α-helical-bundle family of cytokines, can
replace IL-6 during the differentiation of Th17 cells30, 31. Thus, in this work we investigated
the role of IL-21 in the differentiation of IL-22-producing CD4+ T cells. We found that
IL-21 induces the differentiation of CD4+ T cells that produce IL-22, but not IL-17, by a
mechanism that involves the transcription factors STAT3, AhR and RORγt. Moreover, AhR
and IL-21 signaling control IL-22 production by CD4+ T cells that limit mucosal
inflammation in ILC-deficient mice. Taken together, these results indicate that IL-21
signaling controls IL-22 production by T cells that limit mucosal inflammation.
Results
IL-21 induces IL-22 expression in CD4+ T cells
IL-6 triggers the production of IL-22 by naïve CD4+ T cells in the absence of IL-17
production13. Based on the ability of IL-21 to replace IL-6 during the differentiation Th17
cells30, 31, we investigated the role of IL-21 in the differentiation of IL-22 producing CD4+
T cells. We found that the activation of naïve CD4+ T cells with antibodies to CD3 and
CD28 in the presence of IL-21 results in the production of IL-22 but not IL-17 (Figs. 1a-b);
no significant changes in IFNγ expression were detected. The production of IL-22 induced
by activation with IL-21 was comparable to that observed following activation with IL-6
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t(Supplementary Fig. 1a). Moreover, in agreement with previous reports31, 32 we found that
exogenous IL-21 also up-regulated its own expression in T cells (Fig. 1c), suggesting that a
positive feed forward loop stabilizes IL-22 production in IL-21 stimulated T cells. The up-
regulation of il21 expression was reduced by TGFβ1 blockade, suggesting that it is boosted
by trace amounts of TGFβ1 provided either by the medium or the T cells (Supplementary
Fig. 1b).
The production of IL-22 by T cells activated in the presence of IL-21 was associated to
proliferation, peaking at 3 cell divisions as determined by staining with carboxyfluorescein
succinimidyl ester (CFSE)(Fig. 1d). To investigate the stability of IL-22 producing T cells
induced with IL-21, naïve CD4+ T cells were initially activated in the presence of IL-21,
rested, and reactivated in the presence of IL-21, or under Th17 (IL-6 and TGFβ1) or FoxP3
iTreg (TGFβ1) polarizing conditions. The re-stimulation of T cells that have been previously
activated in the presence of IL-21 resulted in a significant population of IL-17- IL-22+ T
cells, similar results were found upon reactivation in the presence of IL-21 (Supplementary
Fig. 2c). Re-stimulation under Th17 polarizing conditions resulted in similar numbers of
IL-17- IL-22+ T cells, however under these experimental conditions we also detected the
generation of IL-17 producing T cells (IL-17+ IL-22+ and IL-17+ IL-22- T cells)
(Supplementary Fig. 2c). Similar results were obtained following re-activation under FoxP3
iTreg polarizing conditions, probably as a result of the promotion of Th17 cell
differentiation by exogenous TGFβ1 acting in combination with T-cell produced IL-2130, 31
(Supplementary Fig. 2c). These results suggest that IL-22 producing T cells induced with
IL-21 are relatively stable, and that additional Th17 cells can be differentiated from non-
polarized T cells in the culture.
Since IL-6 and IL-23 have also been shown to trigger the production of IL-22 by CD4+ T
cells9, 13, 28, 29, we studied the effects of IL-21 on the expression of IL-6R, IL-23R and
IL-21R. T-cell activation in the presence of IL-21 resulted in a significant up-regulation of
il23r expression, but did not modify the expression of il6r or il21r (Fig. 1e), suggesting that
IL-21 signaling may also modulate the production of IL-22 triggered in CD4+ T cells by
IL-23. Similar levels of il21r and il23r expression were observed following T-cell
stimulation in the presence of IL-21 or IL-6 (Supplementary Fig. 1d). In accordance with
these findings, we found a significant synergism between IL-21 and IL-23 in inducing IL-22
expression in CD4+ T cells (Fig. 1f,g). IL-23, however, did not synergize with IL-21 to
boost il21 expression by T cells (Fig. 1h).
IL-1β boosts IL-22 production by Th17 cells33, thus we investigated the effects of IL-1β in
the production of IL-22 triggered by IL-21. We found that IL-21 up-regulated il1r1
expression in T cells, this up-regulation was partially dependent on TGFβ1 signaling (Fig. 1i
and Supplementary Fig. 1d). Moreover, IL-1β synergized with IL-21 in inducing the
production of IL-22, but not of IL-17 (Fig. 1j,k). IL-1β, however, did not boost il21
expression induced by IL-21 (Fig. 1l). Taken together, these results suggest that IL-21, alone
or in combination with IL-23 or IL-1β, triggers IL-22 production independently of IL-17 in
CD4+ T cells.
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tTranscriptional profiling of IL-21-stimulated CD4+ T cells
To study the molecular mechanisms mediating the production of IL-22 by CD4+ T cells
stimulated with IL-21, we analyzed the mRNA expression profile by whole-genome
microarrays. We compared the mRNA expression profiles of naïve CD4+ T cells activated
in the presence of IL-21, IL-6 and TGFβ1 (Th17 cells) or without the addition of exogenous
cytokines (Th0 cells). We found 869 genes that were up- or down-regulated at least 1.5 fold
in CD4+ T cells stimulated in the presence of IL-21 relative to their expression in control
Th0 cells (Fig. 2a). Principal-component analysis (PCA) showed that the transcriptional
signature of CD4+ T cells treated with IL-21 is significantly different from that of Th17
cells differentiated with IL-6 and TGFβ1 (Fig. 2b). Although there was a partial overlap
between genes up-regulated in IL-22+ IL-17- T cells and Th17 cells, a direct comparison of
their transcriptional profile identified 179 genes with differences in expression. We found
significant differences in the expression of key cytokines, chemokines, receptors and
transcription factors recently associated with Th17 cells differentiated in vitro with TGFβ1
and IL-634 (Fig. 2c). We focused our attention on transcriptional modules recently identified
to control Th17 cell differentiation: a module of “Th17-positive factors” that promote Th17
cell differentiation and a module of “Th17-negative factors” that interferes with this
process34. We found that IL-22 producing T cells induced with IL-21 differed from Th17
cells in the expression of genes belonging to these Th17-positive and Th17-negative
transcriptional modules (Fig. 2d).
On the basis of the biological function of their products, we selected a representative subset
of genes coding for transcription factors such as ahr, rora, rorc, tbx21, socs3; granzymes A
and B (gzma and gzmb) which have been linked to effector and regulatory T cells35; the IBD
linked mucin 1 (muc1), known to be a transcriptional target of STAT336-38, and the
inhibitors of IL-10 production metallothioneins 1 and 2 (mt1, mt2)34and confirmed their
differences in expression by qPCR (Fig. 2e). The up-regulation of AhR and RORγt
expression was also confirmed at the protein level by western blot (Fig. 2f). However, and in
agreement with previous reports on IL-22 producing T cells generated with IL-628, this up-
regulation was promoted by trace amounts of TGFβ1 provided either by the medium or the
T cells, because it could be inhibited with TGFβ1-specific blocking antibodies
(Supplementary Fig. 2a). Of note, activation of T cells in the presence of IL-21 did not result
in a significant up-regulation of tbx21, which has been recently linked to the production of
IL-22 triggered in CD4+ T cells IL-629. We also failed to detect foxp3 expression in T cells
activated in the presence of IL-21 (Supplementary Fig. 2b).
Finally, we used Ingenuity Pathways Analysis to analyze the genes found to be differentially
expressed between Th0 and IL-22+ IL-17- T cells. The resulting model identified important
roles for STAT3, RORγt and AhR in the control of IL-22+ IL-17- T cell differentiation
triggered by IL-21 (Fig. 2g). In conclusion, these data suggest that IL-21 triggers a
transcriptional program in CD4+ T cells that differs from the one of Th17 cells and is
controlled by STAT3, RORγt and AhR.
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tSTAT3 is required for IL-21 induced IL-22 expression
Based on our transcriptional analysis and the reported activation of STAT3 by IL-21
signaling, we studied the role of STAT3 in the production of IL-22 triggered by IL-21. T-
cell activation in the presence of IL-21 led to a significant phosphorylation of STAT3, and
also to a significant increase in stat3 expression (Fig 3a-b). T-cell activation in the presence
of IL-6, with or without TGFβ1-blocking antibodies, resulted in similar amounts of STAT3
phosphorylation (Supplementary Fig. 3a).
To investigate the function of STAT3 in the regulation of IL-22 production, we activated
wild type (WT) and STAT3-deficient CD4+ T cells in the presence of IL-21. The production
of IL-22 in response to IL-21 was significantly decreased in STAT3-deficient CD4+ T cells
(Fig. 3c). Moreover, in agreement with our bioinformatic analysis STAT3 was also required
for the up-regulation of il21, ahr and rorc expression in response to IL-21 (Fig. 3d,e).
Of note, we also found that STAT3 mediated the upregulation of il23r and il1r1expression
in response to IL-21 (Fig. 3f). However, IL-23 or IL-1β did not up-regulate stat3 expression
when their effects on CD4+ T cells were analyzed alone or in combination with IL-21 (Fig.
3g). Taken together, these data suggest that STAT3 plays a central role in the differentiation
of IL-22 producing CD4+ T cells in response to IL-21.
RORγt and AhR control IL-22 expression induced by IL-21
The up-regulation of rorc expression was linked to the induction of IL-22 expression in
CD4+ T cells triggered by IL-21 (Fig. 2). Based on our studies on the transcriptional effects
of IL-21 on CD4+ T cells and the reported role of RORγt in the control of il22 expression in
Th17 cells and ILCs16, 39 we investigated the role of RORγt in the production of IL-22
triggered by IL-21. We found that RORγt deficiency led to a significant reduction in the
production of IL-22 induced by IL-21 in naïve CD4+ T cells (Fig. 4a). RORγt-deficiency
also decreased the expression of il23r but not of il1r1, and abrogated the ability of IL-23 to
boost IL-22 production triggered by IL-21 (Fig 4b-c). Conversely, activation of naïve T cells
in the presence of IL-23 or IL-1β alone did not result in a significant upregulation of rorc
expression, but IL-23 synergized with IL-21 to boost rorc expression (Fig. 4d). Thus,
similarly to what has been described for Th17 cells and ILCs, RORγt controls the
production of IL-22 by CD4+ T cells treated with IL-21. Moreover, these data suggest that
in addition to its effects on the production of IL-22 triggered by IL-21, RORγt also controls
the ability of IL-23 to synergize with IL-21 and boost IL-22 expression in T cells.
We20 and others21-23 found that AhR activation modulates IL-22 production in Th17 cells.
Moreover, AhR also participates in the production of IL-22 triggered by IL-628. Based on
these observations and the results of our transcriptional profiling of CD4+ T cells activated
in the presence of IL-21 (Fig. 2), we investigated the role of AhR in the control of IL-22
production triggered by IL-21. The addition of the AhR agonist 6-formylindolo[3,2-
b]carbazole (FICZ) led to a significant increase in the production of IL-22 triggered by
IL-21 (Fig. 4e). Conversely, the use of the AhR specific antagonist CH-223191 resulted in a
significant reduction in IL-22 production triggered by IL-21 (Fig. 4e). A similar reduction in
IL-22 production was detected when we used T cells from AhR-d mice, which carry an ahr
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tallele coding for a mutant AhR with reduced affinity for its ligands40 (Fig. 4f). Of note, ahr
expression levels were not significantly up-regulated in response to T-cell activation in the
presence of IL-23 or IL-1β alone, and IL-23 or IL-1β did not synergize with IL-21 to up-
regulate ahr expression (Fig. 4g). These findings suggest that AhR plays a more important
role in the regulation of IL-22 production by CD4+ T cells activated by IL-21 than in
response to IL-23 or IL-1β.
AhR has been shown to interact with STAT proteins and modulate their activity21, 22, 41.
Considering the important role of STAT3 in the production of IL-22 triggered by IL-21, we
analyzed whether STAT3 activation in response to IL-21 is modulated by AhR. We found
that modulation of AhR signaling with FICZ or CH-223191 had no significant effect in the
phosphorylation of STAT3 in T cells in response to IL-21 (Fig. 4h). Similarly, we found no
significant differences in STAT3 phosphorylation in response to IL-21 between WT and
AhR-d T cells (Supplementary Fig. 3b). Taken together, these data suggest that RORγt and
AhR control the IL-22 production triggered by IL-21, and these effects do not involve the
modulation of STAT3 activation.
STAT3 controls the accessibility of the il22 promoter
We recently reported that AhR and STAT3 co-operate to regulate ikzf3 expression in Th17
cells42. A bioinformatic analysis of the il22 promoter revealed 2 putative STAT3 responsive
elements (SRE-1 and SRE-2) upstream of the transcription start site and 3 putative binding
sites for AhR (xenobiotic response elements, XRE-1, XRE-2 and XRE-3) (Fig. 5a). Thus, to
investigate whether STAT3 and AhR interact with these potential binding sites in the il22
locus we performed chromatin immunoprecipitation (ChIP) assays. We detected a
significant interaction of AhR and STAT3 with the il22 promoter in CD4+ T cells activated
in the presence of IL-21 (Fig. 5b-c).
We then analyzed the functional effects of the interaction of STAT3 and AhR with its DNA
responsive elements using a reporter plasmid carrying the firefly luciferase under the control
of the il22 promoter (il22:Luc). Transfection with vectors coding for AhR or constitutively
activated STAT3 did not result in a significant induction of luciferase activity (Fig. 5d).
However, co-transfection with constructs coding for constitutively activated STAT3 and
AhR induced a significant up-regulation of luciferase activity, suggesting a synergistic effect
of STAT3 and AhR in the production of IL-22 (Fig. 5d).
c-Maf interacts with AhR to transactivate the il10 promoter35, 43, but it suppresses il22
expression induced with IL-628. Although we detected a small up-regulation of maf in
response to IL-21 (Supplementary Fig. 4a), we found no significant binding of c-Maf to its
potential binding sites in the il22 promoter (Supplementary Fig. 4b). These data suggest that,
similarly to what has been described for IL-22+ IL-17- T cells induced with IL-6, c-Maf
does not promote il22 expression in T cells activated in the presence of IL-2128.
Both AhR and RORγt have been shown to control IL-22 expression in Th17 cells. Indeed,
AhR and RORγt physically interact, and in over-expression experiments in EL4 cells it was
shown that a constitutively active mutant AhR is recruited to the il22 locus in a RORγt-
dependent manner16. Since we found that RORγt-deficient T cells show a significant
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tdecrease in IL-22 production following activation in the presence of IL-21, we investigated
whether RORγt was needed for the recruitment of endogenous AhR to its target sequences
in the il22 locus. We found that RORγt deficiency results in a significant decrease in the
recruitment of AhR to the il22 promoter (Fig. 5e). We also detected a decrease in the
acetylation of histones 3 and 4 and the trimethylation of histone 3 at Lys4, concomitant with
increased histone trimethylation at Lys9 and Lys 27, supporting our findings on the lack of
il22 expression in the absence of RORγt (Supplementary Fig. 4c).
Overexpression of AhR and RORγt in CD4+ T cells activated under non-polarizing Th0
conditions, however, does not result in IL-22 expression22. The ability of transcription
factors to bind regulatory regions on target genes is affected by the structure of the
chromatin, which is regulated by several processes including post-translational histone
modifications44. Thus, we reasoned that the lack of IL-22 expression observed in CD4+ T
cells overexpressing AhR and RORγt22might reflect the need for epigenetic mechanisms
that increase the accessibility to regulatory elements in the il22 promoter. First, we analyzed
the acetylation status of histone H3 and H4 in the il22 promoter of naive T cells activated in
the presence of IL-21. We found a significant increase in the acetylation of histones H3 and
H4 in CD4+ T cells activated in the presence of IL-21 (Fig 5f), which is usually associated
with a relaxed chromatin structure that facilitates the interaction of transcription factors with
target sequences. We also found that T-cell activation in the presence of IL-21 results in
increased histone 3 trimethylation in Lys4, associated to actively transcribed genes,
concomitant with decreased trimethylation in Lys9 and Lys27, which have been associated
with the silencing of transcription45 (Fig. 5f). Of note, we detected no changes in the
methylation status of the il22 promoter (Supplementary Fig. 4d).
STAT3 binds target sequences in the il22 promoter and is required for the production of
IL-22 triggered by IL-21 (Figs. 3c and 5c). Given the reported role of STAT3 in regulating
the epigenetic status of target genes46, we investigated the role of STAT3 in regulating the
epigenetic status of the il22 locus using WT and STAT3-deficient T cells activated in the
presence of IL-21. We found that the lack of STAT3 recruitment to the il22 promoter in
STAT3-deficient T cells resulted in a significant decrease in H3 and H4 acetylation in
STAT3 and AhR binding sites (Figs. 5g-i). We also detected a decrease in histone 3
trimethylation at Lys4 and an increase in trimethylation at Lys9 and Lys27 in STAT3-
deficient T cells (Supplementary Fig. 4e). Moreover, the reduced histone acetylation
observed in STAT3-deficient T cells was concomitant with a reduced recruitment of AhR to
the il22 promoter (Fig. 5j). Taken together, these results demonstrate that in addition to its
effects on the expression of AhR and RORγt, STAT3 activated in response to IL-21 controls
the accessibility to regulatory elements in the il22 promoter recognized by AhR and
probably additional transcription factors.
IL-21 and AhR control IL-22 expression in vivo
IL-22 maintains the integrity of the colonic epithelium during inflammation8, 24. Dextran
sodium sulfate (DSS)-induced colitis is thought to result from the disruption of the epithelial
barrier in the colon, resulting in the translocation of commensal bacteria, the activation of
innate immunity and up-regulation of IL-23 and IL-647.
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tIL-22 plays a central role in the control of intestinal inflammation2, 3. Although both ILCs
and CD4+ T cells produce IL-22 during the course of DSS-induced colitis, ILCs constitute a
more abundant source of IL-22 in WT mice (Supplementary Fig. 5). The development of
ILCs is regulated by IL-7 signaling through the IL-2 receptor common gamma chain
(IL-2RG)48. Thus, to focus our studies on the role of IL-22 producing CD4+ T cells during
gut inflammation, we used mice deficient in both RAG2 and IL-2RG (RAG2/IL2RG mice);
these mice lack T cells and also NK cells and ILCs3, 17. To study the role of AhR and IL-21
in the regulation of IL-22 production by T cells in vivo, we reconstituted RAG2/IL2RG mice
with WT CD4+ T cells, IL-21R-deficient (IL-21R KO) T cells or AhR-d T cells. Following
confirmation of successful T-cell reconstitution by flow cytometry from blood samples, we
induced DSS colitis in the recipient mice and monitored weight change daily. We found a
significant worsening of DSS-induced colitis in mice reconstituted with AhR-d or IL-21R-
deficient T cells, manifested as increased weight loss (Fig. 6a) and colon shortening (Fig.
6b) suggestive of augmented colon inflammation. Accordingly, IL-21R KO and AhR-d mice
showed increased colon inflammation upon blind histological examination (Fig. 6c).
To directly investigate the impact of IL-21 and AhR signaling in T cells on the immune
response during DSS-induced colitis, we analyzed cytokine production by excised colon
cultures prepared from mice reconstituted with WT, AhR-d or IL-21R-deficient T cells. We
found a significant reduction in the production of IL-22 by colon explants isolated from
AhR-d or IL-21R deficient mice (Fig. 6d) and a concomitant increase in the levels of the
pro-inflammatory cytokines IL-6 and IL-23 (Fig. 6e). The decreased production of IL-22
correlated with a decrease in the frequency of IL-22 producing T cells in AhR-d and IL21R-
deficient mice compared to WT (Fig. 6f). Of note, we did not detect significant changes in
il10 expression nor in the frequency of FoxP3+ T cells (Fig. 6g). Taken together, these
results demonstrate that IL-21 and AhR signaling in T cells limit gut inflammation.
Discussion
IL-22 regulates tissue homeostasis and inflammation at mucosal surfaces2, 3. ILCs have been
identified as an important source of IL-22 in vivo, but the importance of IL-22 producing T
cells and the mechanisms regulating their differentiation and function are largely unknown.
Human and murine γδ T cells, Th1 and Th17 cells produce IL-222, 3. In addition, IL-22+
IL-17- cells named Th22 cells have been described in humans26, 27 but it has proven
difficult to identify the murine equivalent of this population. CD4+ T-cell activation in the
presence of IL-6, IL-21 or IL-23 induces IL-22+ IL-17- T cells that have been linked to
early host defense against Citrobacter rodentium9, 13, 28, 29, 49. Activation of Notch signaling
has also been shown to induce IL-22 production by CD4+ T cells in a STAT3-independent
manner50. These data suggest that, similarly to what is observed for human Th22 cells,
IL-22 can be expressed independently of IL-17 in mouse T cells. However, until specific
transcription factors are identified to act as master regulators of IL-22+ IL-17- T cells, it
cannot be determined whether these cells constitute a separate CD4+ T cell lineage or
simply represent an activation stage of CD4+ T cells.
IL-21 is produced by NKT cells, γδ T cells, follicular helper T cells, Th17 cells, type 1
regulatory T cells and a recently described subpopulation of mucosal CCR9+ Th cells43, 51.
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cells in vivo. We found that IL-21 up-regulates rorc expression, and also il1r1 and il23r in a
RORγt-dependent manner. Indeed, IL-21 synergized with IL-1β and IL-23 to induce IL-22
production by CD4+ T cells. These data suggest that by increasing il1r1 and il23r
expression, IL-21 decreases the activation threshold for IL-1β and IL-23-triggered IL-22
production. In addition, IL-6 has also been shown to induce IL-21 production by T cells32.
Thus, it is likely that similarly to their reported effects on Th17 cell differentiation52, IL-21
acts in combination with IL-23, IL-1β and IL-6 to stabilize and boost the production of
IL-22 by T cells in vivo. IL-21 can replace IL-6 during the differentiation of Th17 cells, and
IL-21 and IL-6 exhibit redundancy during the differentiation of follicular T helper
cells30, 31, 51, however that redundancy is not complete in vivo53. Future studies should
determine the relative contribution of IL-6 and IL-21, and also IL-1β and IL-23 during the
regulation of IL-22 production by T cells and other cell populations.
Group 3 ILCs comprises an heterogeneous group of cell populations identified as a major
source of IL-22 in vivo2, 14, 24. Interestingly, AhR and RORγt are reported to control IL-22
production by ILCs in response to IL-23, a known activator of STAT3 signaling15, 16. These
reports and the data presented in this manuscript highlight the transcriptional similarities
existing between CD4 T cells activated in the presence of IL-21 and group 3 ILCs, and
suggest that additional transcriptional elements involved in the control of IL-22 expression
might be shared by these two sources of IL-22. Of note, it has been recently shown that T-
bet controls the production of IL-22 production triggered with IL-629. In our experiments we
did not detect an up-regulation of tbx21 following T-cell activation in the presence of IL-21.
This finding suggests that similarly to the heterogeneity that characterizes the RORγt+
IL-22+ cells included in group 3 ILCs, distinct IL-22+ IL-17- CD4+ T cell populations
might be induced in response to different environmental, microbial and cytokine stimuli.
Because of the dominant role of ILCs and γδ T cells in mucosal IL-22 production we used
T-cell reconstituted RAG2/IL-2RG mice to study the role of T-cell produced IL-22 in
mucosal inflammation. We found that IL-21 and AhR modulate the production of IL-22 by
intestinal CD4+ T cells in vivo. In addition, it has been reported that the protective effects of
some AhR dietary ligands in the DSS colitis model are T-cell dependent, suggesting that
IL-22 production by T cells plays a physiological role in the modulation of mucosal
inflammation54. Additional support for this interpretation was recently provided by Basu et
al, who described sequential waves of IL-22 production by ILCs and T cells responsible for
host defense against Citrobacter rodentium infection29. Indeed, it is possible that specialized
ILCs with antigen-presenting cell activity participate in the induction and regulation of
IL-22 producing mucosal T cells in vivo55. The study of the factors that control IL-22
production by different cell types is likely to identify appropriate targets for the therapeutic
modulation of IL-22 production.
A partial protection from DSS-induced colitis has been previously reported in complete,
non-tissue specific IL-21 deficient mice56. We believe that the differences on the role of
IL-21 on DSS-induced colitis (protective in our work versus pathogenic in56) might reflect
differential effects of IL-21 on ILCs and CD4+ T cells and the absence of ILCs in RAG2/
IL2RG mice. Alternatively, these different outcomes might result from the use of IL-21
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tdeficient mice in the work of Araki et al56, instead of the IL-21R KO mice used in our
studies.
We found that AhR modulates IL-22 production by IL-22+ IL-17- T cells induced with
IL-21, but AhR inhibition does not completely abrogate IL-22 production in vitro. Similar
results have been recently reported for the role of AhR in the regulation of IL-22 production
triggered in CD4+ T cells by IL-628. Our data, however, suggest that AhR plays a more
prominent role in the regulation of IL-22 production in vivo. A large proportion of intestinal
IL-22+ T cells co-express IL-17, probably as a result of the local abundance of TGFβ1
which in combination with IL-6 and IL-21 favors the differentiation of Th17 cells that may
control intestinal inflammation8, 57. Indeed, our experiments using blocking antibodies
indicate that TGFβ1 promotes AhR expression in IL-22 producing T cells. Th17 cells
differentiated in the presence of TGFβ1 express higher amounts of AhR, and consequently
AhR is a stronger regulator of IL-22 expression in Th17 cells than in IL-22+ IL-17- T
cells28. Thus, the more prominent effects of AhR in the regulation of IL-22 in vivo might
reflect the increased role of Th17 cells as a source of intestinal IL-22. It is also possible that
local AhR ligands provided by the host, the diet or the commensal flora are more potent
inducers of IL-22 expression in intestinal T cells.
We and others have shown that AhR controls IL-22 and IL-10 production by Th1720, 22, 23
and Tr135, 43, 58 cells. Considering the importance of IL-10 and IL-22 for the control of
mucosal homeostasis and inflammation2, 3, 59, AhR seems to be closely linked to a
transcriptional program that limits immunopathology at environmental interfaces by the
combined effects of IL-10 on the adaptive and the innate immune response, and the effects
of IL-22 on epithelial cells. The regulation of AhR activity by endogenous, microbial,
dietary and environmental ligands, provides a molecular mechanisms to adjust the mucosal
production of IL-10 and IL-22. Moreover, it provides a potential target for therapeutic
intervention.
Methods
Mice
Eight weeks old C57BL/6 and double RAG2- IL-2RG-deficient female mice were purchased
from the Jackson Laboratories. AhR-d, IL21R- and RORγt-deficient mice were breed at
Harvard Medical School, from breeders provided by the Jackson Laboratories. Mice were
kept in a conventional, pathogen-free facility at the Harvard Institutes of Medicine. All
mouse handling and in vivo experiments were carried out in accordance with guidelines
prescribed by the Institutional Animal Care and Use Committee (IACUC) at Harvard
Medical School.
T-cell differentiation in vitro
Naïve CD4+ T cells were stimulated were stimulated with plate bound antibodies against
CD3 (145-2C11, 2μg/ml) and CD28 (PV-1, 2μg/ml), in the presence of IL-21 (30ng/ml) or
IL-21 (30ng/ml) and IL-23 (30ng/ml) to generate Th22 cells; and IL-6 (30ng/ml), TGFβ1
(3ng/ml). Mouse IL-6, IL-21, IL-23 and TGFβ1 were purchased from R&D Systems. In
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tsome experiments we used TGFβ1-blocking antibodies at a final concentration of 10 ug/ml
from R&D (Cat. #AF-101-NA). FICZ was obtained from Enzo Life Sciences (PA, USA)
and CH-223191 from EMD Chemicals (NJ, USA). We used an RPMI-based medium to
minimize the activation of the cells by tryptophan-derived AhR ligands present in other
tissue culture mediums22. RPMI was supplemented with 0.1 mM nonessential amino acids,
1 mM sodium pyruvate, L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 U/
ml), 10% heat-inactivated FBS (BioWhittaker, Inc.) and 2-mercaptoethanol. To evaluate the
stability of IL-22 producing T cells induced with IL-21, in some experiments after an initial
phase of activation in the presence of IL-21, T cells were re-stimulated with plate bound
antibodies to CD3 and CD28 for 48h in the presence of medium, IL-21, TGFβ1 or
TGFβ1and IL-6.
Cytokine Analysis
Secreted cytokines were measured in supernatants of differentiated CD4+ T cells in vitro
and in supernatants of colon samples ex vivo after 48h by ELISA. For intracellular cytokine
staining, cells were stimulated for 4h at 37C in culture medium containing PMA (50 ng/ml;
Sigma, USA), ionomycin (1 μg/ml; Sigma) and GolgiStop (1 μl/ml; BD Biosciences, USA).
After staining for the surface markers CD3 and CD4, cells were fixed and permeabilized
using Cytofix/Cytoperm and Perm/Wash according to the manufacturer's instruction (BD
Biosciences, USA; eBioscience, USA). All antibodies were purchased from Biolegend and
eBioscience. Data were acquired on a FACSCalibur (BD Biosciences) and analyzed using
the FlowJo software (Tree Star).
qPCR
RNA was extracted with RNAeasy columns (Qiagen, USA). cDNA was prepared using
High Capacity cDNA Reverse Transcriptase kit following the manufacturer's instructions
(Applied Biosystems, USA) and used as template for real-time PCR. Probes were purchased
from Applied Biosystems, and were used on the ViiA™ 7 Real-Time PCR System (Applied
Biosystems). Expression was normalized to the expression of gapdh. The following probe
mixtures were used: il1r (Mm01226962_m1), il6r (Mm00439653_m1), il21r
(Mm00600319_m1), il23r (Mm00519942_m1), il10 (Mm0043614_m1), il17
(Mm00439619_m1), il21 (Mm00517640_m1), il22 (Mm00444241_m1), ahr
(Mm01291777_m1), maf (Mm02581355_s1), rora (Mm01173766_m1), rorc
(Mm00441144_g1), stat3 (Mm01219775_m1), foxp3 (Mm00475156_m1), socs3, mt1
(Mm00496660_g1), mt2 (Mm00809556_s1), gzma (Mm01304452_m1), gzmb
(Mm00442834_m1), tbx21 (Mm00450960_m1), gapdh (Mm99999915_g1).
Gene expression analysis
Transcriptome analysis was done using Affymetrix microarray MoGene_1_0_st on CD4+ T
cells stimulated for 48 h in the presence of medium, IL-21 or IL-6 and TGFβ1. Microarray
data was analyzed using GeneSpring version12.5 software package (Agilent, Santa Clara,
CA). Samples were normalized using Quantile Normalization Algorithm. Fold change
difference between IL-21-treated and untreated naïve CD4+ T cells was calculated to
observe the differential expression profile of genes. Hierarchical clustering was performed
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ton genes with fold change >=1.5 using Euclidean distance metric to generate heat-maps. We
also performed Principle Component Analysis (PCA) to observe the separation between
samples using GeneSpring version 7.3 software package (Agilent, Santa Clara, CA). GEO:
microarray data GSE55509.
Western blot analysis
Cells were lysed with RIPA buffer supplemented with protease inhibitor cocktail (Sigma,
USA). Total T cell lysates (20 μg) were resolved on 4–12% Bis-Tris Nupage gels
(Invitrogen, USA) and transferred onto PVDF membranes (Millipore). The following
primary antibodies were used: Anti-AhR from Enzo Life Sciences (BML-SA210; 1/2000
dilution); anti-RORγt from Abcam (Cat. #78007; 1/1000 dilution) and anti-GAPDH from
Cell Signaling Technology (Cat. #2111; 1/1000 dilution). Western blot analysis was
performed as described60 and developed using SuperSignal West Femto Maximum
Sensitivity Substrate, as instructed by the manufacturer (Pierce).
Chromatin immunoprecipitation (ChIP)
Cells were cross-linked with 1% paraformaldehyde and lysed with 0.35 ml of lysis buffer
(1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) containing 1X protease inhibitor
cocktail (Roche Molecular Biochemicals, USA). Chromatin was sheared by sonication and
supernatants were collected after centrifugation and diluted in buffer (1% Triton X-100, 2
mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1). Five μg of antibody was prebound
for a minimum of 4 h to protein A and protein G Dynal magnetic beads (Invitrogen, USA)
and washed three times with ice-cold PBS plus 5% BSA, and then added to the diluted
chromatin and immunoprecipitated overnight. The magnetic bead-chromatin complexes
were then washed 3 times in RIPA buffer (50 mM HEPES [pH 7.6], 1 mM EDTA, 0.7% Na
deoxycholate, 1% NP-40, 0.5 M LiCl) followed by 2 times with TE buffer.
Immunoprecipitated chromatin was then extracted with 1% SDS, 0.1 M NaHCO3 and heated
at 65°C for at least 6 h to reverse the paraformaldehyde cross-linking. DNA fragments were
purified with a QIAquick DNA purification Kit (Qiagen, USA) and analyzed using SYBR
green real time PCR (Takara Bio Inc., USA). We used the following antibodies for ChIP:
anti-pSTAT3 (Cat. #9132, Cell Signaling Technology, Inc., USA), anti-AhR (Cat. #9172,
Cell Signaling Technology, Inc., USA), anti-cmaf (Cat. #9172, Cell Signaling Technology,
Inc., USA), anti-Acetyl-H3 (Cat. #06-599, Millipore, MA, USA), Acetyl-H4 (Cat. #06-866,
Millipore, MA, USA), anti-H3K4me3 (Cat. #ab8580, Abcam, MA, USA), anti-H3K9me3
(Cat.#ab8898, Abcam, MA, USA) and anti-H3K27me3 (Cat. #6002, Abcam, MA, USA).
The primer pairs used in these experiments are listed in Supplementary Table 1.
Methyl-DNA immunoprecipitation
The T cells were harvested after washing with PBS and genomic DNA was isolated using a
DNeasy Blood and Tissue kit (Qiagen) and sheared by sonication to obtain DNA fragments
of approximately 500 bp. Ten microgram of sheared DNA was heated at 95°C for 10 min
and snap-chilled before mixing with 10 ul of freshly prepared protein A and protein G Dynal
magnetic beads (Invitrogen) that were pre-incubated with 5 ug of either anti-5-methyl-
cytidine antibody (Cat. #ab10805) or mouse IgG control antibody (Cat. #ab18413), both
from Abcam, for a minimum of 4 hr and washed 3 times with ice-cold PBS plus 5% BSA.
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tThe mixture was then incubated overnight in buffer (20 mM Tris-HCl [pH 8.1], 150 mM
NaCl, 2 mM EDTA, 1% Triton X-100). The bead-DNA complexes were then washed three
times in RIPA buffer (50 mM HEPES [pH 7.6], 1 mM EDTA, 0.7% Na deoxycholate, 1%
NP-40, 0.5 M LiCl) followed by three times with TE buffer (10 mM Tris HCl [pH 8.0], 1
mM EDTA). Immunoprecipitated DNA was then extracted by heating at 65°C in 1% SDS,
0.1 M NaHCO3 for at least 6 hr. DNA fragments were purified with a QIAquick DNA
purification Kit (Qiagen) and analyzed using SYBR -green real time PCR. The primer pairs
used in these experiments are listed in Supplementary Table 2.
Transfection and luciferase assays
HEK293 cells were grown in DMEM supplemented with 10% fetal bovine serum, and
transfected using the FuGENE HD (Roche, USA) transfection reagent according the
manufacturer's instructions. il22 promoter reporter construction was purchased from Dr.
Renauld (Ludwig Institute for Cancer Research and Experimental Medicine Unit, Universite
Catholique de Louvain, Brussels, Belgium). Vectors coding for AhR and c-Maf were
purchased from Gene CopoeiaInc (MD, USA), the vector coding for constitutively activated
STAT3 was provided by Dr. David Frank (Dana-Farber Cancer Institute, Boston, MA,
USA). Firefly and renilla luciferase activity was analyzed 48 h after transfection using a dual
luciferase assay kit (Promega, USA).
T-cell Transfer and Colitis induction
Sorted splenic CD4+ T cells from C57BL/6, AhR-d and IL21R knock out mice were
transferred i.p.(10 × 10 6 cells/mouse) into double RAG2- IL-2RG-deficient mice. One
month after T cell transfer, the recipient mice were checked for reconstitution of CD4+ T
cells and colitis was induced with DSS. 3% DSS (MW:36.000-50.000. MP Biomedicals,
LLC) was dissolved in drinking water and administered for 7 days, and weight was
monitored daily. Eight days after the initiation of the treatment with DSS the mice were
euthanized, the colons were dissected and their length measured from the ileocecal junction
to the anal verge.
Histological evaluation of colitis
Colonic tissue was removed and used for histologic evaluation by 2 independent
investigators in a blinded fashion. The total histologic score represents the sum of
nonulcerative regions of epithelium and an infiltration score ranging from 0 to 6 as follows:
epithelium: 0, normal morphology; 1, loss of goblet cells in small areas; 2, loss of goblet
cells in large areas; infiltration: 0, no infiltration; 1, infiltration around crypt basis; 2,
infiltration reaching the lamina muscularis mucosae; 3, extensive infiltration reaching the
lamina muscularis mucosae and thickening of the mucosa with abundant edema; 4,
infiltration of the lamina submucosa.
Ex vivo colon culture and ELISA
Sections of 1cm of the colon were excised, longitudinally halved and washed three times
with sterile HBSS+Hepes medium (2% HEPES buffer, 1% penicillin/streptomycin and
0,05% gentamicin). The colon sections were placed into culture in complete Bruff's media
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tand cultured for 72h at 37°C with 5% CO2. The supernatants were harvested and the
concentrations of IL-22 (Antigenix America), IL-6 and IL-23 (eBioscience) were
determined by ELISA according to manufacturer's instructions.
Statistical analysis
Statistical analysis was performed using the Prism software (Graph Pad software, La Jolla,
CA, USA). P<0.05 were considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. IL-21 promotes the differentiation of CD4+ T cells that produce IL-22 but not IL-17
Naïve WT CD4+ T cells were stimulated in vitro with antibodies to CD3 and CD28 in the
presence of different cytokines as indicated. (a-b) Effect of IL-21 in the production of IL-22
and IL-17 measured by ELISA in culture supernatants (a) and qPCR (b). (c) Effect of IL-21
on the expression of il21. (e) Effect of IL-21 on the expression of il6r, il21r, il23r. (d)
Relationship between cell division and IL-22 expression in CD4+ T cells. CFSE-labeled
naïve CD4+ T cells were activated in the presence of IL-21 and the production of IL-22 was
analyzed by intracellular staining. The data are shown as the Mean fluorescence intensity
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t(MFI) for IL-22 for each division cycle. (e) Effects of IL-21 on the expression of il6r, il21r
and il23r. (f-h) Synergistic effects of IL-21 and IL-23 on IL-22 (f) and IL-17 (g) cytokine
and il21 expression (h). (i) Effect of IL-21 on il1r expression. (j-l) Synergistic effects of
IL-21 and IL-1β on IL-22 (j), Il17a (k) and il21 (l) expression. mRNA expression is shown
relative to gapdh. Results are representative of 3-5 independent experiments.* P < 0.05, **
P < 0.01 and *** P < 0.001 (one-way ANOVA).
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tFigure 2. Transcriptional profiling of IL-21-stimulated CD4+ T cells
Naïve WT CD4+ T cells were stimulated in vitro with antibodies to CD3 and CD28 in the
presence of IL-21, IL-6 and TGFβ1 or without addition of exogenous cytokines. (a)
Heatmap showing genes with at least a 1.5 fold change in expression relative to Th0 as
determined by whole-genome microarrays. (b) Principal-component analysis (PCA). (c-d)
Heatmaps depicting the expression of key cytokines, chemokines, receptors and
transcription factors (c) and transcriptional modules (d) that control the differentiation of
Th17 cells as defined in34. (e) Quantitative RT-PCR analysis of the expression of genes in
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tFig. 2a. mRNA expression is shown relative to gapdh. (f) Western blot analysis of the
expression of AhR (95kDa) and RORγt (58kDa) on T cells activated in the presence of
IL-21 or under Th17-polarizing conditions (left panel). Quantification of western blot
reactivity (right panel). (g) Ingenuity Pathways Analysis of the transcriptional response of
naïve CD4+ T cells to IL-21. * P < 0.05, ** P < 0.01 and *** P < 0.001 (one-way
ANOVA).
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tFigure 3. STAT3 controls the production of IL-22 by CD4+ T cells stimulated with IL-21
(a-b) NaïveWT CD4+ T cells were activated in the presence of IL-21 or IL-6 and TGFβ1.
(a) FACS analysis of phosphorylated STAT3. Mean fluorescence intensity (MFI) of
phosphorylated STAT3 normalized to total STAT3. (b) qPCR analysis of stat3 expression.
(c-f) Naïve WT and STAT3-deficient CD4+ T cells were activated in the presence of IL-21
or IL-6 and TGFβ1. (c) Effect of STAT3 deficiency on IL-22 and IL-17 production. (d)
Effect of STAT3 deficiency on il21 expression. (e-f) Effect of STAT3 deficiency on ahr and
rorc expression (e) and the receptors il1r, il23r (f). (g) Induction of stat3 by IL-1β, IL-21
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tIL-23, IL-1β and IL-21 or IL-21 and IL-23. mRNA expression is shown relative to gapdh.
Results are representative of 2-3 independent experiments. * P < 0.05, ** P < 0.01 and ***
P < 0.001 (one-way ANOVA and Student's t- test).
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tFigure 4. RORγt and AhR control IL-22 production by CD4+ T cells stimulated with IL-21
(a-c) Naïve WT and RORγt-deficient CD4+ T cells were activated in the presence of IL-21
or IL-6 and TGFβ1. (a) Effect of RORγt deficiency on IL-22 and IL-17 production. (b)
Effect of RORγt deficiency on il23r and il1r1expression. (c) Effect of RORγt deficiency on
the synergism between IL-21 and IL-23. (d) Effect of IL-1β and IL-23 in rorc expression.
(e) Effect of the modulation of AhR activity on IL-22 and IL-17 production. (f) IL-22
production by WT and AhR-d CD4+ T cells activated in the presence of IL-21. (g)
Modulation of ahr expression by IL-1β and IL-23. (h) Effect of AhR modulation on STAT3
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tphosphorylation and stat3 expression. MFI of phosphorylated STAT3 normalized to total
STAT3. mRNA expression is shown relative to gapdh. Representative results of 2-3
independent experiments. * P < 0.05, ** P < 0.01 and *** P < 0.001 (one-way ANOVA and
Student's t- test).
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tFigure 5. STAT3 controls AhR recruitment to the il22 promoter in IL-21-stimulated CD4+ T
cells
(a) AhR, c-Maf and STAT3 binding sites in the il22 promoter. (b-c) WT naïve CD4+ T cells
were stimulated in vitro with antibodies to CD3 and CD28 in the presence or absence of
IL-21. ChIP analysis of the interaction of AhR (b) and STAT3 (c) to the AhRand STAT3
binding sites in the il22 promoter, respectively. (d) Regulation of the transcriptional activity
of the il22 promoter by AhR and STAT3. A reporter construct for the il22 promoter
(il22:Luc) was cotransfected in HEK293 cells with vector coding for AhR and/or
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tconstitutively activated STAT3 (STAT3c). Firefly luciferase was determined and
normalized to renilla luciferase activity. (e) ChIP analysis of the recruitment of AhR to the
il22 promoter in WT and RORγt-deficient CD4+ cells activated in the presence of IL-21. (f)
WT naïve CD4+ T cells were stimulated in vitro with antibodies to CD3 and CD28 in the
presence or absence of IL-21, and the epigenetic status of the il22 promoter was analyzed by
ChIP using antibodies to Acetyl-H3, Acetyl-H4 and H3 trimethylated at Lys4, Lys9 or
Lys27. (g-j) ChIP analysis of the epigenetic status of the il22 promoter in WT and STAT3-
deficient CD4+ T cells activated in the presence of IL-21. STAT3 recruitment (g), H3 and
H4 acetylation in SREs (h) and XREs (i) and AhR recruitment (j) in the il22 promoter.
Results are representative of 2-3 independent experiments. * P < 0.05, ** P < 0.01 and ***
P < 0.001 (one-way ANOVA).
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tFigure 6. IL-21 and AhR control IL-22 + CD4+ T cells in vivo and limit mucosal inflammation
(a) RAG2/IL2RG mice transferred with WT, AhR-d or IL-21R deficient CD4+ T cells were
given 3 % DSS ad libitum in their drinking water for 7 days. Body weight was assessed
daily, and the percent mass change from day 0 was calculated. Mean ± s.e.m is shown, n=5
mice per group. Effect of genotype on disease course P<0.0001, *P<0.01 by two-way
ANOVA. (b) Colon length at day 7 after treatment with DSS. (c) Colonic histological
sections were scored as described in Methods. Values are mean ± s.e.m. (d-e) Colons were
excised on day 7 after the initiation of treatment with DSS, cultured for 3 days and IL-22
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t(d), IL-6 and IL-23 (e) were quantified in the supernatants by ELISA. (f-h) Lymphocytes
from the colonic lamina propria (LPL) were isolated. The frequency of IL-22+IL17-,
IL-22+IL-17+, IL-22-IL-17+ T cells (f) and FoxP3+ Tregs (g) was analyzed by FACS and
the expression of il10 was measured by qPCR (h). mRNA expression is shown relative to
the expression of gapdh. Results are representative of 3 independent experiments. * P <
0.05, ** P < 0.01 and *** P < 0.001 (one-way ANOVA and two-way ANOVA).
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